CR9108A - Prevencion de infecciones endoparasitas verticales - Google Patents

Prevencion de infecciones endoparasitas verticales

Info

Publication number
CR9108A
CR9108A CR9108A CR9108A CR9108A CR 9108 A CR9108 A CR 9108A CR 9108 A CR9108 A CR 9108A CR 9108 A CR9108 A CR 9108A CR 9108 A CR9108 A CR 9108A
Authority
CR
Costa Rica
Prior art keywords
endoparasites
prevention
vertical
infections
andoparasiticide
Prior art date
Application number
CR9108A
Other languages
English (en)
Inventor
Bach Thomas
Tanzler Janina
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of CR9108A publication Critical patent/CR9108A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se refiere al uso de depsipeptidos andoparasiticidas para la preparacion de medicamentos para la prevencion de infeccion vertical con endoparasitos
CR9108A 2004-11-16 2007-05-09 Prevencion de infecciones endoparasitas verticales CR9108A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004055316A DE102004055316A1 (de) 2004-11-16 2004-11-16 Verhinderung vertikaler Endoparasiten-Infektionen

Publications (1)

Publication Number Publication Date
CR9108A true CR9108A (es) 2007-09-11

Family

ID=35767587

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9108A CR9108A (es) 2004-11-16 2007-05-09 Prevencion de infecciones endoparasitas verticales

Country Status (29)

Country Link
US (1) US20090215678A1 (es)
EP (1) EP1814572B1 (es)
JP (1) JP5078619B2 (es)
KR (1) KR101280511B1 (es)
CN (1) CN101102785B (es)
AR (1) AR052133A1 (es)
AT (1) ATE469652T1 (es)
AU (1) AU2005306070B2 (es)
BR (1) BRPI0518172A (es)
CA (1) CA2587537C (es)
CR (1) CR9108A (es)
DE (2) DE102004055316A1 (es)
DK (1) DK1814572T3 (es)
ES (1) ES2345265T3 (es)
HR (1) HRP20100471T1 (es)
IL (1) IL183200A (es)
MX (1) MX2007005766A (es)
MY (1) MY142727A (es)
NO (1) NO341472B1 (es)
NZ (1) NZ555117A (es)
PE (1) PE20061079A1 (es)
PL (1) PL1814572T3 (es)
PT (1) PT1814572E (es)
RU (1) RU2405565C2 (es)
SI (1) SI1814572T1 (es)
TW (1) TWI358293B (es)
UA (1) UA91694C2 (es)
WO (1) WO2006053641A1 (es)
ZA (1) ZA200703982B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
CN104023710A (zh) * 2011-12-21 2014-09-03 拜耳知识产权有限责任公司 包含无定形艾默德斯的制剂
CN107835818B (zh) 2015-05-20 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
BR112018013369A2 (pt) 2015-12-28 2019-02-19 Merial, Inc. compostos depsipeptídicos anti-helmínticos
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
IL274283B2 (en) 2017-11-07 2025-03-01 Bayer Animal Health Gmbh Method for the synthesis of cyclic depsipeptides
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2362539C2 (de) * 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
NZ249588A (en) * 1992-03-17 1996-08-27 Fujisawa Pharmaceutical Co Anthelmintic agent
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
US5747448A (en) * 1993-02-19 1998-05-05 Meiji Seika Kaisha, Ltd. Derivatives of cyclodepsipeptide PF 1022
DE69400631T2 (de) * 1993-05-05 1997-02-27 Palo Alto Medical Foundation, Palo Alto, Calif. Verwendung von rifamycinderivaten zur herstellung eines arzneimittels zur behandlung der toxoplasmose
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
NZ271739A (en) * 1993-09-06 1996-09-25 Fujisawa Pharmaceutical Co Cyclodepsipeptide compounds and pharmaceutical compositions thereof
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
DE4401389A1 (de) * 1994-01-19 1995-07-20 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung
DE4406025A1 (de) * 1994-02-24 1995-08-31 Bayer Ag Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung
DE4437198A1 (de) * 1994-10-18 1996-04-25 Bayer Ag Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
ATE425973T1 (de) * 1995-06-30 2009-04-15 Astellas Pharma Inc Depsipeptid-derivat, verfahren zu dessen herstellung und zwischenprodukt dafur
ATE299871T1 (de) * 1995-09-22 2005-08-15 Meiji Seika Kaisha Neue zyklische depsipeptid pf1022 derivate
DE19545639A1 (de) * 1995-12-07 1997-06-12 Bayer Ag Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen
DE19962147A1 (de) * 1999-12-22 2001-06-28 Bayer Ag Schädlingsbekämpfungsmittel / PF 1022-221
US20010036922A1 (en) * 2000-04-03 2001-11-01 Benchaoui Hafid Abdelaali Method of treating a parasitic infection
GB0008353D0 (en) * 2000-04-03 2000-05-24 Pfizer Ltd Method of treating a parasitic infection
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel

Also Published As

Publication number Publication date
MY142727A (en) 2010-12-31
JP5078619B2 (ja) 2012-11-21
WO2006053641A1 (de) 2006-05-26
PT1814572E (pt) 2010-08-02
DE102004055316A1 (de) 2006-05-18
PE20061079A1 (es) 2006-11-30
CA2587537C (en) 2014-06-03
CA2587537A1 (en) 2006-05-26
PL1814572T3 (pl) 2010-11-30
DE502005009697D1 (de) 2010-07-15
NZ555117A (en) 2009-11-27
NO20073023L (no) 2007-08-10
MX2007005766A (es) 2007-07-16
KR20070084412A (ko) 2007-08-24
KR101280511B1 (ko) 2013-07-01
CN101102785A (zh) 2008-01-09
HRP20100471T1 (hr) 2010-10-31
EP1814572A1 (de) 2007-08-08
BRPI0518172A (pt) 2008-11-04
NO341472B1 (no) 2017-11-20
AU2005306070B2 (en) 2011-05-12
HK1117041A1 (en) 2009-01-09
AU2005306070A1 (en) 2006-05-26
RU2007122284A (ru) 2008-12-27
EP1814572B1 (de) 2010-06-02
IL183200A (en) 2011-12-29
US20090215678A1 (en) 2009-08-27
DK1814572T3 (da) 2010-09-20
UA91694C2 (ru) 2010-08-25
CN101102785B (zh) 2011-05-18
JP2008520598A (ja) 2008-06-19
SI1814572T1 (sl) 2010-09-30
ATE469652T1 (de) 2010-06-15
RU2405565C2 (ru) 2010-12-10
ES2345265T3 (es) 2010-09-20
IL183200A0 (en) 2007-08-19
TW200626140A (en) 2006-08-01
TWI358293B (en) 2012-02-21
ZA200703982B (en) 2008-08-27
AR052133A1 (es) 2007-03-07

Similar Documents

Publication Publication Date Title
ECSP077316A (es) Compuestos imidazo-3-il-amina bicíclicos sustituidos
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
BRPI0411528A (pt) uso de isomalte como prebiótico
ECSP10010722A (es) Compuestos orgánicos
CL2008002228A1 (es) Compuestos derivados de imidazopiridinonas, agonista de tlr7; procedimiento de preparacion; compuestos intermediarios; composiicon farmaceutica que los comprende; y uso en infecciones virales, bacterianas y fungicas.
ATE528989T1 (de) Kristalline feste rasagilin-base
ECSP099044A (es) Compuestos de pirimido fusionados
BRPI0807487A8 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
HN2004000490A (es) Procedimiento para la preparacion de una composicion farmaceutica solida administrable oralmente
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
CL2011000691A1 (es) Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias.
BR122020006906B8 (pt) compostos e composições farmacêuticas antivirais
CR9108A (es) Prevencion de infecciones endoparasitas verticales
CR8428A (es) Agente endoparasiticidas para la administracion topica
MA31849B1 (fr) Nouveaux dérivés de pyrimidine
BRPI0518904A2 (pt) formulaÇÕes de nepafenac tàpicas
CL2011001215A1 (es) Compuestos derivados de pirimidina, inhibidores de tirosina quinasa; composiciones farmaceuticas que los comprenden; y su uso en el tratamiento y/o prevencion de cancer, enfermedades inflamatorias y enfermedades autoinmunes.
CL2008002295A1 (es) Compuestos derivados de tiazolida sustituidos con alquilsulfonilos; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
CR9223A (es) 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
ECSP11011054A (es) Péptidos antivirales terapéuticos
CL2011000165A1 (es) Compuestos derivados de indolinonas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento y/o la prevencion del cancer, infecciones, enfermedades inflamatorias y autoinmunes.
CL2008001728A1 (es) Compuestos derivados de indolinonas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de cancer, infecciones, enfermedades inflamatorias y autoinmunes.